Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT1A/1B/2C receptors

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 2, 2003, Pages 371-380

  Miranda, F ^a   Hong, E ^b   Sanchez H ^c   Velazquez Martinez D N ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antagonists; Drug discrimination, (rat); Indorenate; Serotonin receptors

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; ANXIOLYTIC AGENT; DRUG VEHICLE; INDORENATE; KETANSERIN; LITHIUM CHLORIDE; MESULERGINE; METERGOLINE; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SODIUM CHLORIDE; TROPISETRON; 5 METHOXYTRYPTAMINE; DRUG DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEGRADATION; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG POTENCY; DRUG RECEPTOR BINDING; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; TASTE AVERSION; TRAINING; ANIMAL; DOSE RESPONSE; DRUG EFFECT; PERCEPTIVE DISCRIMINATION; TASTE;

5-METHOXYTRYPTAMINE; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; MALE; RATS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TASTE;

EID: 0037212859     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)01010-9     Document Type: Article

References (73)

1. 2 agonist in rats. Pharmacol. Toxicol. 64:1989;165-172.
2. Arnt J. Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD and St 587 in rats. Behav. Pharmacol. 3:1992;11-18.
3. 1A receptor antagonisms BMY7378 and NAN190. Eur. J. Pharmacol. 217:1992;163-171.
4. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci. 16:1995;105-110.
5. 1B receptor cell line. Eur. J. Pharmacol. 360:1998;117-121.
6. 1 agonist. Proc. West. Pharmacol. Soc. 43:1991;433-437.
7. Bourson A., Wanner D., Wyler R., Petit N., Zwingelstein C., Rudler A.et al. Pharmacological evaluation of the discriminative stimulus of metachlorophenylpiperazine. Pharmacol. Biochem. Behav. 53:1996;107-114.
8. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Eur. J. Pharmacol. 257:1994;27-38.
9. (1F), receptor subtype. Br. J. Pharmacol. 132:2001;991-998.
10. 2A) receptors in the mediation of the discriminative stimulus properties of (±)DOI in rats. Pol. J. Pharmacol. 45:1997;299-304.
11. Conn P.J., Sanders-Bush E. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1C) receptors. J. Pharmacol. Exp. Ther. 242:1987;552-557.
12. 1A receptor antagonist WAY100635. Eur. J. Pharmacol. 264:1994;95-97.
13. 1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP). J. Pharmacol. Exp. Ther. 237:1986;369-377.
14. Cunningham K.A., Callahan P.M., Appel J.B. Differentiation between the stimulus effects of L-5-hydroxytryptophan and LSD. Eur. J. Pharmacol. 108:1985;179-186.
15. Cunningham K.A., Callahan P.M., Appel J.B. Discriminative stimulus properties of the serotonin agonist MK 212. Psychopharmacology. 90:1986;193-197.
16. 1D autoreceptors. Br. J. Pharmacol. 114:1995;1107-1109.
17. 1 binding sites as target for a novel putative anxiolytic. Naunyn-Schmiedeberg's Arch. Pharmacol. 328:1985;467-470.
18. 4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;403-410.
19. 1A receptor in the anxiolytic action of indorenate and ipsapirone. Psychopharmacology. 101:1990;354-358.
20. 1A compounds by GABA-benzodiazepine agents in rats. Pharmacol. Biochem. Behav. 60:1998;27-32.
21. Fernández-Guasti A., Escalante A., Hong E., Agmo A. Behavioral actions of the serotonergic anxiolytic indorenate. Pharmacol. Biochem. Behav. 37:1990;83-88.
22. 2C receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology. 119:1995;222-230.
23. 1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward. Psychopharmacology. 142:1999;165-174.
24. Glennon R.A. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci. 39:1986;825-830.
25. Glennon R.A., McKenney J.D., Young R. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP). Life Sci. 35:1984;1475-1480.
26. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol. 154:1988;339-341.
27. 2C receptor mode of action. Psychopharmacology. 137:1998;292-302.
28. 1A receptor antagonists NAN190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur. J. Pharmacol. 211:1992;211-219.
29. Grignaschi G., Fanelli E., Scagnol I., Samanin R. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats. Br. J. Pharmacol. 127:1999;1190-1194.
30. Hartig P.R. Molecular biology of 5-HT receptors. Trends Pharmacol. Sci. 10:1989;64-69.
31. 7 binding site in mouse ileum. Eur. J. Pharmacol. 387:2000;265-272.
32. Hong E. A serotonergic antihypertensive agent. In: Singer TP, Ondarza R, (Editors) Molecular Basis of Drug Action. New York: Elsevier/North-Holland; 1981. p. 247-51.
33. Hong E., Rion R., Aceves J., Benitez-King G., Anton-Tay F. Further evidence for a central antihypertensive effect of indorenate. Proc. West. Pharmacol. Soc. 30:1987;1-3.
34. 1 recognition sites. J. Recept. Res. 8:1988;59-81.
35. Hoyer D., Schoeffter P. 5-HT receptors: subtypes and second messengers. J. Recept. Res. 11:1991;197-214.
36. 3H]ketanserin. Eur. J. Pharmacol. 118:1985;13-23.
37. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J.et al. VII. International union of pharmacology classification of receptors for 5-Hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
38. 2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin. J. Med. Chem. 33:1990;755-758.
39. 2 receptor subtype in the Suncus murinus intestine. Eur. J. Pharmacol. 381:1999;161-169.
40. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117:1996;427-434.
41. Kleven M.S., Koek W. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences. J. Pharmacol. Exp. Ther. 284:1998;238-249.
42. 2A/2C antagonist anxiolytics. Drug discrimination and behavioral observation studies in rats. J. Pharmacol. Exp. Ther. 282:1997;747-759.
43. 1A receptor activation and antidepressant-like effects: F13714 has high efficacy and marked antidepressant potential. Eur. J. Pharmacol. 420:2001;103-112.
44. 3H-ligand binding sites in vitro. J. Physiol. 77:1981;351-362.
45. Leysen J.E., Gommeren W., Van Gompel P., Wynants J., Janssen P.F., Laduron P.M. Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol. Pharmacol. 27:1985;600-611.
46. López M., Velazquez-Martínez D.N., Prado R., García G., Ortiz R. Effects of the intracerebroventricular administration of indorenate and fenfluramine on spontaneous behavior and food intake in rats. Proc. West. Pharmacol. Soc. 34:1991;465-468.
47. 1B mechanism. Pharmacol. Biochem. Behav. 24:1986;43-47.
48. 2A) in the consolidation of learning. Behav. Brain Res. 89:1997;217-223.
49. 1 recognition site. Eur. J. Pharmacol. 90:1983;151-153.
50. Middlemiss D.N., Tricklebank M.D. Centrally active 5-HT receptor agonists and antagonists. Neurosci. Biobehav. Rev. 16:1992;75-82.
51. Miranda F., Hong E., Velázquez-Martínez D.N. Discriminative stimulus properties of indorenate in a conditioned taste aversion paradigm. Pharmacol. Biochem. Behav. 68:2001;427-433.
52. 1A receptor agonist flesinoxan in pigeons. Eur. J. Pharmacol. 325:1997;145-153.
53. Nava-Felix P., Hong E. Nature of the central serotonin receptor mediating hypotension. J. Cardiovasc. Pharmacol. 1:1979;461-466.
54. Neill J.C., Bendotti C., Samanin R. Studies on the role of 5-HT receptors in satiation and the effect of f-fenfluramine in the runway test. Eur. J. Pharmacol. 190:1990;105-112.
55. Pazos A., Cortes R., Palacios J.M. Quantitative receptor autoradiography: application to the characterization of multiple receptor subtypes. J. Recept. Res. 4:1984;645-656.
56. Pearce J.M. Animal Learning and Cognition: An Introduction. 1997;Psychology Press, East Sussex.
57. Peroutka S.J. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol. Psychiatry. 20:1985;971-979.
58. 1C binding sites in rat frontal cortex. J. Neurochem. 47:1986;529-540.
59. Ramírez J.I., Sánchez H., López Cabrera M., Velázquez-Martínez D.N. Evidence that methiothepin enhanced the anorectic effect of indorenate. Proc. West. Pharmacol. Soc. 41:1998;57-58.
60. 2C agonist: a study in rats. J. Psychopharmacol. 15:2001;29-36.
61. 1B ligands exist? Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;675-683.
62. Schreiber R., Brocco M., Millan M.J. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur. J. Pharmacol. 264:1994;99-102.
63. 1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. J. Pharmacol. Exp. Ther. 275:1995;822-831.
64. 35S]GTPγS binding. Eur. J. Pharmacol. 320:1997;267-275.
65. 3 receptors in the mediation of the ethanol interoceptive cue. Eur. J. Pharmacol. 309:1996;141-147.
66. (1B) receptor ligands on self-administration of ethanol in an operant procedure in rats. Pharmacol. Biochem. Behav. 66:2000;129-136.
67. 1A receptor. Eur. J. Pharmacol. 133:1987;47-56.
68. Velázquez-Martínez D.N., Valencia M., López-Cabrera M., Villarreal J.E. Effects of indorenate on food intake: a comparison with fenfluramine and amphetamine. Psychopharmacology. 117:1995;91-101.
69. Velázquez-Martínez D.N., López-Cabrera M., Sánchez H., Ramírez J.I., Hong E. Discriminative stimulus properties of indorenate, a serotonin agonist. J. Psychiatry Neurosci. 24:1999;122-130.
70. Vicentic A., Li Q., Battaglia G., Van de Kar L.D. WAY10035 inhibits 8-OH-DPAT stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur. J. Pharmacol. 346:1998;261-266.
71. Winter J.C. Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine. Pharmacol. Biochem. Behav. 29:1988;193-195.
72. Winter J.C., Rabin R.A. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin. Eur. J. Pharmacol. 235:1993;237-243.
73. Ybema C.E., Slangen J.L., Olivier B., Mos J. Discriminative stimulus properties of the serotonergic compound eltoprazine. J. Pharmacol. Exp. Ther. 260:1992;1045-1051.